BIORESOURCE TECHNOLOGY

Medix Biochemica is a Finnish global leader in developing and manufacturing critical raw materials for the in vitro diagnostics (IVD) industry. Established in 1985, the company specializes in supplying over 5,000 high-quality products including monoclonal and polyclonal antibodies, recombinant antigens, proteins, enzymes, molecular reagents, and processed biologicals. With operations across Europe (Finland, France, Germany), North America (USA), and China, and approximately 293 employees, Medix Biochemica derives over 90% of revenue from international exports. The company holds ISO 13485 certification and FDA QSR compliance, supporting over 10 billion laboratory tests worldwide. Beyond product supply, Medix Biochemica offers custom services including antibody development, contract manufacturing, bioassay development, and specialized plasma processing tailored to diagnostic assay manufacturers' needs.